Skip to main content

ADVERTISEMENT

edetate disodium-based chelation therapy

Editor's Corner
10/12/2022

Craig Walker, MD, FACC, FACP

 

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD, FACC, FACP   Card...
Dr. Walker comments on the article by Ujueta and Lamas, "Is There a Role for Edetate Disodium Chelation in PAD and Specifically CLTI?"
Dr. Walker comments on the article by Ujueta and Lamas, "Is There a Role for Edetate Disodium Chelation in PAD and Specifically CLTI?"
Dr. Walker comments on the...
10/12/2022
Vascular Disease Management
Video
10/12/2022

Craig Walker, MD, FACC, FACP

 

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD, FACC, FACP   Card...
Watch Dr. Walker's commentary on further investigation of chelation therapy.
Watch Dr. Walker's commentary on further investigation of chelation therapy.
Watch Dr. Walker's commentary on...
10/12/2022
Vascular Disease Management
Commentary
10/12/2022

Francisco Ujueta, MD, MS1; Gervasio A. Lamas, MD1,2

 

1Columbia University Division of Cardiology, Mount Sinai Medical Center, Miami Beach, Florida; 2Department of Medicine, Mount Sinai Medical Center, Miami Beach, Florida

Francisco Ujueta, MD, MS1; Gervasio A...
In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.
In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.
In this commentary, the authors...
10/12/2022
Vascular Disease Management
Endovascular Techniques
06/14/2019

Francisco Ujueta, MD1; Gervasio A. Lamas, MD1,2

 

1Department of Medicine, Mount Sinai Medical Center, Miami Beach, Florida; 2Columbia University Division of Cardiology, Mount Sinai Medical Center, Miami Beach, Florida

Francisco Ujueta, MD1; Gervasio A. La...
We offered a regimen of 50 TACT infusions to an individual with ‘no treatment option’ for revascularization and scheduled for major amputation. The patient was able to avoid amputation with improvement in his quality of life.
We offered a regimen of 50 TACT infusions to an individual with ‘no treatment option’ for revascularization and scheduled for major amputation. The patient was able to avoid amputation with improvement in his quality of life.
We offered a regimen of 50 TACT...
06/14/2019
Vascular Disease Management